News

• 12.11.2024

  Two New Professors at CITCO

  CITCO is strengthened by the appointment of two professors in Hematology Department X. Chief Physician, Ph.D. Thomas Stauffer Larsen, leads the CAR-T cell program in the department and clinical research in the field of lymphoma, while Chief Physician, Ph.D. Henrik Frederiksen becomes head of research and joins CITCO's management team. Both play key roles in CITCO's success in implementing CAR-T cell therapy at OUH. Both professorships are affiliated with the Research Unit for Hematology at the Clinical Institute of the University of Southern Denmark.

• 04.11.2024

  JACIE accreditation of CITCO

  CITCO has achieved JACIE accreditation, marking an important milestone. This international accreditation is a quality seal for our two departments: Hematology Department X and the Clinical Immunology Department.

• 25.10.2023

  First patient with bone marrow cancer treated with CAR-T in Denmark

  CITCO has now treated its first myeloma patient with CAR-T cells

• 31.08.2023

  Doctor, Ph.D. Mike Bogetofte Barnkob receives an award for his research

  Doctor, Ph.D. Mike Bogetofte Barnkob has been honored as the recipient of the 'Exceptional Young Scientist Award' at the Danish Cancer Research Days in Odense, organized by the Danish Comprehensive Cancer Center (DCCC).

• 24.03.2022

  Researchers from OUH produce genetically engineered cells on a clinical scale for advanced cancer treatment

  First CAR-T product completed at the Department of Clinical Immunology, Odense University Hospital